Clinical Trial Update: Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone [NA]

View source ↗

Summary

Completed clinical trial evaluating augmentation of treatment-resistant depression with an analog of allopregnanolone; results were posted on February 18, 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Zuranolone (zuranolone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | NA | Status: COMPLETED | Results posted: 2019-02-18